Prescribing indicators at primary health care centers within the WHO African region: A systematic analysis (1995-2015)

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Ofori Asenso, Richard ^a   Brhlikova, Petra ^b   Pollock, Allyson M ^b  

^a Research Unit   (Ghana)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Africa; Drug use indicators; Medicine utilization studies; Pharmacoepidemiology; Prescribing evaluation; Prescribing indicators; Systematic reviews

Indexed keywords

ANTIINFECTIVE AGENT; ESSENTIAL DRUG;

AFRICA; CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; INJECTION; META ANALYSIS; PRESCRIPTION; PRIMARY HEALTH CARE; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; STANDARDS; TRENDS; UTILIZATION; WORLD HEALTH ORGANIZATION;

AFRICA; ANTI-BACTERIAL AGENTS; DELIVERY OF HEALTH CARE; DRUG PRESCRIPTIONS; DRUGS, ESSENTIAL; GUIDELINE ADHERENCE; HEALTH RESOURCES; HUMANS; INJECTIONS; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION;

EID: 84983070585     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-3428-8     Document Type: Article

References (95)

1. World Health Organization. The world medicines situation. Geneva: World Health Organization; 2004.
2. Laing R. Rational drug use; an unsolved problem. Trop Dr. 1990;20:101-3.
3. Massele A, Burger J, Katende-Kyenda NL, Kalemeera F, Kenaope T, Kibuule D, Mbachu O, Mubita M, Oluka M, Olusanya A, et al. Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa. Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):885-8.
4. World Health Organization. World medicines situation report 2011. Geneva: World Health Organization; 2011.
5. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240-9.
6. Fraser S. Rational use of essential medicines. World Health Forum. 1985;6:36-66.
7. Odusanya O, Oyediran M. Rational drug use at primary health care centres in Lagos, Nigeria. Nig Q J Hosp Med. 2000;10(1):4-7.
8. Babalola C, Awoleye S, Akinyemi J, Kotila O. Evaluation of prescription pattern in Osun State (Southwest) Nigeria. J Public Health Epidemiol. 2011;3(3):94-8.
9. Gustafsson LL, Wettermark B, Godman B, Andersen-Karlsson E, Bergman U, Hasselstrom J, Hensjo LO, Hjemdahl P, Jagre I, Julander M, et al. The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108(4):224-33.
10. World Health Organization. How to investigate drug use in health facilities: selected drug use indicators - EDM research series No. 007. WHO/DAP/93.1. Geneva: World Health Organization; 1993.
11. Hogerzeil HV, Bimo, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, Azad Chowdhury AK, Das AM, Kafle KK, Mabadeje AF, et al. Field tests for rational drug use in twelve developing countries. Lancet. 1993;342(8884):1408-10.
12. Harvard Medical School and Harvard Pilgrim Health, World Health Organization. Using indicators to measure country pharmaceutical situations Fact Book on WHO Level I and Level II monitoring indicators, edn. Geneva: World Health Organization; 2006.
13. Dumoulin J, Kaddar M, Velásquez G. Guide to drug financing mechanisms. Geneva: World Health Organization; 1998.
14. World Health Organization, Harvard Medical School and Harvard Pilgrim Health. Medicines use in primary care in developing and transitional countries Fact Book summarizing results from studies reported between 1990 and 2006. Geneva: World Health Organization; 2009.
15. Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degnan D. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Tropical Med Int Health. 2013;18(6):656-64.
16. World Health Organization Regional Office for Africa. Atlas of African Health Statistics 2016 - Health situation analysis of the African Region. Brazzaville: Republic of Congo World Health Organization; 2016.
17. Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.
18. Maher D, Smeeth L, Sekajugo J. Health transition in Africa: practical policy proposals for primary care. Bull World Health Organ. 2010;88(12):943-8.
19. Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis. PLoS One. 2014;9(8):e104300.
20. Moeti M. Fighting non-communicable diseases: an overview of Africa's New Silent Killers. In: African Health Monitor. vol. 8, January-June 2008 edn. Brazzaville: World Health Organization Regional Office for Africa: 2-5.
21. Whitlock EP, Lin JS, Chou R, Shekelle P, Robinson KA. Using existing systematic reviews in complex systematic reviews. Ann Intern Med. 2008;148(10):776-82.
22. Trap B, Hansen EH, Hogerzeil HV. Prescription habits of dispensing and non-dispensing doctors in Zimbabwe. Health Policy Plan. 2002;17(3):288-95.
23. Ofori-Asenso R. A closer look at the World Health Organization's prescribing indicators. J Pharmacol Pharmacother. 2016;7(1):51-4.
24. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-12.
25. Yin X, Song F, Gong Y, Tu X, Wang Y, Cao S, Liu J, Lu Z. A systematic review of antibiotic utilization in China. J Antimicrob Chemother. 2013;68(11):2445-52.
26. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-84.
27. Cousineau D, Chartier S. Outliers detection and treatment: a review. Int J Psychol Res. 2010;3(1):58-67.
28. Abdella S, Wade N. Prescribers adherence to the basic principles of prescrption orders writing in South West Ethiopia. Natl J Physiol Pharm Pharmacol. 2012;2(1):66-70.
29. Adisa R, Fakeye T, Aindero V. Evaluation of prescription pattern and patients' opinion on healthcare practices in selected primary healthcare facilities in Ibadan, South-Western Nigeria. Afr Health Sci. 2015;15(4):1318-29.
30. Afriyie D, Tetteh R. A description of the pattern of rational drug use in Ghana Police Hospital. Int J Pharm Pharmacol. 2014;3(1):143-8.
31. Afriyie DK, Amponsah SK, Antwi R, Nyoagbe SY, Bugyei KA. Prescribing trend of antimalarial drugs at the Ghana Police Hospital. J Infect Dev Ctries. 2015;9(4):409-15.
32. Ahiabu MA, Tersbol BP, Biritwum R, Bygbjerg IC, Magnussen P. A retrospective audit of antibiotic prescriptions in primary health-care facilities in Eastern Region, Ghana. Health Policy Plan. 2016;31(2):250-8.
33. Angamo M, Wabe N, Raju N. Assessment of Patterns of Drug use by using World Health Organization's Prescribing, Patient Care and Health facility indicators in Selected Health Facilities in Southwest Ethiopia. J Appl Pharm Sci. 2011;1(7):62-6.
34. Ball DE, Maidza J, Rusike T, Sharief K, Taderera T, Tangawarima T. Drug use indicators at St Mary's Clinic. Cent Afr J Med. 2000;46(2):54-5.
35. Bantie L. Assessment of prescribing practice pattern in Governmental Health Centers of Bahir Dar Town, Ethiopia. World J Pharm Sci. 2014;2(10):1184-90.
36. Bexell A, Lwando E, von Hofsten B, Tembo S, Eriksson B, Diwan VK. Improving drug use through continuing education: a randomized controlled trial in Zambia. J Clin Epidemiol. 1996;49(3):355-7.
37. Boonstra E, Lindbaek M, Khulumani P, Ngome E, Fugelli P. Adherence to treatment guidelines in primary health care facilities in Botswana. Tropical Med Int Health. 2002;7(2):178-86.
38. Boonstra E, Lindbaek M, Ngome E. Adherence to management guidelines in acute respiratory infections and diarrhoea in children under 5 years old in primary health care in Botswana. Int J Qual Health Care. 2005;17(3):221-7.
39. Bosu WK, Ofori-Adjei D. An audit of prescribing practices in health care facilities of the Wassa West district of Ghana. West Afr J Med. 2000;19(4):298-303.
40. Desta Z, Abula T, Beyene L, Fantahun M, Yohannes AG, Ayalew S. Assessment of rational drug use and prescribing in primary health care facilities in north west Ethiopia. East Afr Med J. 1997;74(12):758-63.
41. Dippenaar H, Joubert G, Van Rooyen C. How cheap is primary health care? Cost per script at the Heidedal Community Health Centre and National District Hospital in Bloemfontein. S Afr Fam Pract. 2005;47(7):37-40.
42. Enato E, Sounyo A, Madadi P. Assessment of disease profiles and drug prescribing patterns of health care facilities in Edo state, Nigeria. J Public Health Africa. 2012;3(e25):101-6.
43. Enato E, Mohammed A, Dayom D, Ekpe P. Medication prescribing practices of healthcare professionals in primary health centres in Niger State, Nigeria. J Pharm Bioresources. 2013;10(1):1-7.
44. Isah H. Prescription pattern among care providers in Catholic-church-owned primary health care facilities in the Northern Ecclesiastical provinces of Abuja, Jos and Kaduna,Nigeria: Preliminary findings. J Pharm Allied Sci. 2008;5(2).
45. Kapp P, Klop A, Jenkins L. Drug interactions in primary health care in the George subdistrict, South Africa: a cross-sectional study. S Afr Fam Pract. 2013;55(1):78-84.
46. Katende-Kyenda N, Lubbe M, Serfontein J, Truter I. Antimicrobial prescribing patterns in a group of private primary health care clinics in South Africa. Health SA Gesondheid. 2007;12(1):21-9.
47. Krause G, Borchert M, Benzler J, Heinmuller R, Kaba I, Savadogo M, Siho N, Diesfeld HJ. Rationality of drug prescriptions in rural health centres in Burkina Faso. Health Policy Plan. 1999;14(3):291-8.
48. Massele AY, Nsimba SE. Comparison of drug utilisation in public and private primary health care clinics in Tanzania. East Afr Med J. 1997;74(7):420-2.
49. Massele AY, Nsimba SE, Rimoy G. Prescribing habits in church-owned primary health care facilities in Dar Es Salaam and other Tanzanian coast regions. East Afr Med J. 2001;78(10):510-4.
50. Massele A, Nsimba S, Fulgence J. A survey of Prescribing practices of Health care workers in Kibaha District in Tanzania. Tanzan Med J. 2007;22(1):31-3.
51. Massele A, Mashalla Y, Mwamba N. The impact of patient-prescriber interaction group discussions on injection prescribing in public and private primary health care facilities in Kinondoni district. J Phys Pharm Adv. 2012;2(9):295-300.
52. Meyer JC, Summers RS, Moller H. Randomized, controlled trial of prescribing training in a South African province. Med Educ. 2001;35(9):833-40.
53. Mohlala G, Peltzer K, Phaswana-Mafuya N, Ramlagan S. Drug prescription habits in public and private health facilities in 2 provinces in South Africa. East Mediterr Health J. 2010;16(3):324-8.
54. Nsimba SE, Massele AY, Makonomalonja J. Assessing prescribing practice in church-owned primary healthcare (PHC) institutions in Tanzania: a pilot study. Trop Doct. 2004;34(4):236-8.
55. Nsimba S. Assessing prescribing and patient care indicators for children under five years old with malaria and other disease conditions in public primary health care facilities. Southeast Asian J Trop Med Public Health. 2006;37(1):206-14.
56. Olayemi SO, Akinyede AA, Oreagba AI. Prescription pattern at primary health care centres in Lagos State. Niger Postgrad Med J. 2006;13(3):220-4.
57. Oyeyemi AS, Ogunleye OA. Rational use of medicines: assessing progress using primary health centres in Shomolu local government area of Lagos, Nigeria. West Afr J Med. 2013;32(2):121-5.
58. Phillips-Howard PA, Wannemuehler KA, ter Kuile FO, Hawley WA, Kolczak MS, Odhacha A, Vulule JM, Nahlen BL. Diagnostic and prescribing practices in peripheral health facilities in rural western Kenya. AmJTrop Med Hyg. 2003;68(4 Suppl):44-9.
59. Risk R, Naismith H, Burnett A, Moore SE, Cham M, Unger S. Rational prescribing in paediatrics in a resource-limited setting. Arch Dis Child. 2013;98(7):503-9.
60. Savadogo L, Ilboudo B, Kinda M, Boubacar N, Hennart P, Dramaix M, Donnen P. Antibiotics prescribed to febrile under-five children outpatients in urban public health services in Burkina Faso. Health Policy Plan. 2014;6(2):165-70.
61. Shiferaw G, Gedif T, Gebre-Mariam T. Drug utilization pattern in selected Health Facilities in Bahir Dar and West Gojam Zones, Northwest Ethiopia. Ethiop Pharm J. 2010;28:55-62.
62. Sisay A, Mekonnen H. Assessment of prescribers adherence to the basic standards of prescription order writing in serbo and assendabo health centres, Jimma Zone, South West Ethiopia. Int J Pharm Sci Res. 2012;3(10):3806-13.
63. Suleman S, Sabitu K, Idris S. Elimination of unnecessary injection through health education on injection safety and rational prescription among primary health care workers in Katsina State. Niger Jos J Med. 2013;7(1):15-20.
64. Tamuno I. Traditional medicine for HIV infected patients in antiretroviral therapy in a tertiary hospital in Kano, Northwest Nigeria. Asian Pac J Trop Med. 2011;4(2):152-5.
65. Truter I. The Phelophepa Health Care Train: a pharmacoepidemiological overview of the Western Cape in 2009. S Afr Fam Pract. 2010;52(5):463-6.
66. Tsega B, Hailu W, Ergetie Z. Measuring quality of drug use in primary health care facilities: a year long assessment of WHO prescribing indicators, Wolkite Town South West Ethiopia. Int J Pharm Ind Res. 2012;2(4):485-91.
67. Uzochukwu BS, Onwujekwe OE, Akpala CO. Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria. Health Policy Plan. 2002;17(4):378-83.
68. de-Graft Aikins A, Unwin N, Agyemang C, Allotey P, Campbell C, Arhinful D. Tackling Africa's chronic disease burden: from the local to the global. Glob Health. 2010;6:5.
69. von Lueder TG, Atar D. Comorbidities and polypharmacy. Heart Fail Clin. 2014;10(2):367-72.
70. Fitzgerald SP, Bean NG. An analysis of the interactions between individual comorbidities and their treatments - implications for guidelines and polypharmacy. J Am Med Dir Assoc. 2010;11(7):475-84.
71. Dagli RJ, Sharma A. Polypharmacy: a global risk factor for elderly people. J Int Oral Health. 2014;6(6):i-ii.
72. National Research Council. (2006). Aging in Sub-Saharan Africa: Recommendations for Furthering Research. Panel on Policy Research and Data Needs to Meet the Challenge of Aging in Africa. Barney Cohen and Jane Menken, Eds. Committee on Population, Division of Behavioral and Social Sciences and Education. Washington, DC: The National Academies Press.
73. Velkoff V, Kowal P. Aging in Sub-Saharan Africa: the changing demography of the region. In: Cohen B, Menken J, editors. Aging in Sub-Saharan Africa: recommendation for furthering research. edn. Washington: National Academies Press (US); 2006.
74. Patterson SM, Cadogan CA, Kerse N, Cardwell CR, Bradley MC, Ryan C, Hughes C. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;10:CD008165.
75. Schacht W. Drug patent expirations: potential effects on pharmaceutical innovation. Congressional Research Service; 2012.
76. Godman B, Bishop I, Campbell SM, Malmstrom RE, Truter I. Quality and efficiency of statin prescribing across countries with a special focus on South Africa: findings and future implications. Expert Rev Pharmacoecon Outcomes Res. 2015;15(2):323-30.
77. Woerkom M, Piepenbrink H, Godman B, Metz J, Campbell S, Bennie M, Eimers M, Gustafsson LL. Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. J Comp Eff Res. 2012;1(6):527-38.
78. Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514-26.
79. Gagne JJ, Choudhry NK, Kesselheim AS, Polinski JM, Hutchins D, Matlin OS, Brennan TA, Avorn J, Shrank WH. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med. 2014;161(6):400-7.
80. Veronin M. Should we have concerns with generic versus brand antimicrobial drugs? A review of issues. J Pharm Health Serv Res. 2011;2:135-50.
81. Paton C. Generic clozapine: outcomes after switching formulations. Br J Psychiatry. 2006;189:184-5.
82. Nwolisa CE, Erinaugha EU, Ofoleta SI. Prescribing practices of doctors attending to under fives in a children's outpatient clinic in Owerri, Nigeria. J Trop Pediatr. 2006;52(3):197-200.
83. Nicolosi E, Gray A. Potential cost savings from generic medicines-protecting the prescribed minimum benefits. South Africa Family Practice. 2009;51(1):60-63.
84. Cameron A, Laing R. Cost savings of switching private sector consumption from originator brand medicines to generic equivalents; World Health Report (2010) Background Paper, 35. Geneva: World Health Organization; 2010.
85. Godman B, Bishop I, Finlayson AE, Campbell S, Kwon HY, Bennie M. Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Rev Pharmacoecon Outcomes Res. 2013;13(4):469-82.
86. Abuelkhair M, Abdu S, Godman B, Fahmy S, Malmstrom RE, Gustafsson LL. Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Rev Pharmacoecon Outcomes Res. 2012;12(1):115-24.
87. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229-41.
88. Md Rezal RS, Hassali MA, Alrasheedy AA, Saleem F, Md Yusof FA, Godman B. Physicians' knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev Anti-Infect Ther. 2015;13(5):665-80.
89. Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract. 2010;27(6):684-90.
90. Polage CR, Bedu-Addo G, Owusu-Ofori A, Frimpong E, Lloyd W, Zurcher E, Hale D, Petti CA. Laboratory use in Ghana: physician perception and practice. AmJTrop Med Hyg. 2006;75(3):526-31.
91. Massele AY, Mwaluko GM. A study of prescribing patterns at different health care facilities in Dar es Salaam, Tanzania. East Afr Med J. 1994;71(5):314-6.
92. Wang H, Li N, Zhu H, Xu S, Lu H, Feng Z. Prescription pattern and its influencing factors in Chinese county hospitals: a retrospective cross-sectional study. PLoS One. 2013;8(5):e63225.
93. Laing R, Waning B, Gray A, Ford N, t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361(9370):1723-9.
94. Narendran R, Narendranathan M. Influence of pharmaceutical marketing on prescription practices of physicians. J Indian Med Assoc. 2013;111(1):47-50.
95. Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med. 2007;4(4):e150.